Glioblastoma – or glioblastoma multiforme – is an aggressive type of brain tumor for which there is currently no cure and which usually results in death within a few months of diagnosis. Glioblastomas are the most frequently diagnosed form of malignant brain tumors among adults.
Statistically, the survival time of glioblastoma patients amounts on average to 12-14 months after diagnosis, but it can be also considerably higher in individual cases. Final cause of death is due to the space-occupied by the lesion, as well as the tumor-related accumulation of fluid in the brain tissue, which places excessive pressure on vitally important regions of the brain.
The Anni Hofmann Foundation exclusively supports medical research on glioblastoma. It aims to explore the body’s own ways of defending itself against malignancies and stabilizing healthy cell generation.